ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

U-Ploid Biotechnologies Ltd

U-Ploid Biotechnologies Ltd is an active company incorporated on 22 January 2024 with the registered office located in Oxford, Oxfordshire. U-Ploid Biotechnologies Ltd was registered 1 year 9 months ago.
Status
Active
Active since incorporation
Company No
15432020
Private limited company
Age
1 year 9 months
Incorporated 22 January 2024
Size
Micro
Turnover is under £1M
Under 10 employees
Confirmation
Submitted
Dated 1 August 2025 (3 months ago)
Next confirmation dated 1 August 2026
Due by 15 August 2026 (9 months remaining)
Last change occurred 1 year 3 months ago
Accounts
Submitted
For period 22 Jan31 Jan 2025 (1 year)
Accounts type is Total Exemption Full
Next accounts for period 31 January 2026
Due by 31 October 2026 (11 months remaining)
Address
Building 696, Innovation Building, Bioescalator Old Road Campus, Roosevelt Drive
Headington
Oxford
OX3 7FZ
England
Address changed on 18 Dec 2024 (10 months ago)
Previous address was 94 London Road Headington Oxford OX3 9FN England
Telephone
Unreported
Email
Unreported
Website
Unreported
People
Officers
4
Shareholders
4
Controllers (PSC)
2
PSC • Director • British,american • Lives in UK • Born in Dec 1985
Director • Australian,american • Lives in United States • Born in Apr 1978
Director • British • Lives in England • Born in Dec 1994
Director • British • Lives in England • Born in Nov 1993
Dr Chloe Amelia Charalambous
PSC • British • Lives in England • Born in Dec 1994
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Everlon Holdings Ltd
Dr Jordan Abdi is a mutual person.
Dissolved
Financials
Net Assets, Total Assets & Total Liabilities (2025–2025)
Period Ended
31 Jan 2025
For period 31 Jan31 Jan 2025
Traded for 12 months
Cash in Bank
£702.17K
Turnover
Unreported
Employees
3
Total Assets
£874.27K
Total Liabilities
-£26.98K
Net Assets
£847.29K
Debt Ratio (%)
3%
Latest Activity
Dr Chloe Amelia Charalambous Details Changed
3 Months Ago on 1 Aug 2025
Confirmation Submitted
3 Months Ago on 1 Aug 2025
Full Accounts Submitted
7 Months Ago on 20 Mar 2025
Registered Address Changed
10 Months Ago on 18 Dec 2024
Doctor Jeremy James Anthony Buzzard Appointed
1 Year 1 Month Ago on 25 Sep 2024
Dr Alexandre Webster Details Changed
1 Year 1 Month Ago on 22 Sep 2024
Dr Chloe Amelia Charalambous Details Changed
1 Year 1 Month Ago on 22 Sep 2024
Dr Chloe Amelia Charalambous (PSC) Details Changed
1 Year 1 Month Ago on 22 Sep 2024
Dr Alexandre Webster (PSC) Details Changed
1 Year 1 Month Ago on 22 Sep 2024
Chloe Amelia Charalambous (PSC) Appointed
1 Year 3 Months Ago on 23 Jul 2024
Get Credit Report
Discover U-Ploid Biotechnologies Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Director's details changed for Dr Chloe Amelia Charalambous on 1 August 2025
Submitted on 4 Aug 2025
Confirmation statement made on 1 August 2025 with no updates
Submitted on 1 Aug 2025
Resolutions
Submitted on 29 May 2025
Total exemption full accounts made up to 31 January 2025
Submitted on 20 Mar 2025
Registered office address changed from 94 London Road Headington Oxford OX3 9FN England to Building 696, Innovation Building, Bioescalator Old Road Campus, Roosevelt Drive Headington Oxford OX3 7FZ on 18 December 2024
Submitted on 18 Dec 2024
Appointment of Doctor Jeremy James Anthony Buzzard as a director on 25 September 2024
Submitted on 8 Oct 2024
Change of details for Dr Alexandre Webster as a person with significant control on 22 September 2024
Submitted on 24 Sep 2024
Change of details for Dr Chloe Amelia Charalambous as a person with significant control on 22 September 2024
Submitted on 24 Sep 2024
Director's details changed for Dr Chloe Amelia Charalambous on 22 September 2024
Submitted on 24 Sep 2024
Director's details changed for Dr Alexandre Webster on 22 September 2024
Submitted on 24 Sep 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year